Package 70010-125-03

{"route": ["ORAL"], "spl_id": "4377481d-43ac-f347-e063-6394a90acc90", "openfda": {"upc": ["0370010125032", "0370010126039", "0370010127036"], "unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["61e9cbe3-8211-42f3-b68f-581f56651919"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-125-03)", "package_ndc": "70010-125-03", "marketing_start_date": "20250331"}, {"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-125-05)", "package_ndc": "70010-125-05", "marketing_start_date": "20250331"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-125-06)", "package_ndc": "70010-125-06", "marketing_start_date": "20250331"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "70010-125_4377481d-43ac-f347-e063-6394a90acc90", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70010-125", "generic_name": "bupropion hydrochloride", "labeler_name": "Granules Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA218385", "marketing_category": "ANDA", "marketing_start_date": "20250331", "listing_expiration_date": "20261231"}